Samuel D Banister
Biographic Data
| ID | 7961682 |
|---|---|
| NAME | Samuel D Banister |
| GIVEN NAMES | Samuel D |
| FAMILY NAME | Banister |
| SIGNATURE | BANISTER S D |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0002-4690-4318 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-Butica, MMB-4CN-Butinaca, MDMB-4F-Butica, MDMB-4F-Butinaca and their analogs
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo , use of SCRAs can result in severe intoxication, in addition to other adverse health effects. Recent detections of AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA and MDMB-4F-BUTINACA mark a continuation in the appea…
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-Fubinaca, Cumyl-Pinaca, PB-22, and XLR-11
These results suggest that while some "off-targets" could possibly contribute to the SCRA toxidrome, particularly at high concentrations, CB1-mediated cellular dysfunction provides support for hypotheses concerning on-target, rather than off-target, toxicity. Further investigation of non-GPCR off-targets is warranted
Synthetic cannabis’
No prominent works on this page.
Synthetic cannabis’
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-Butica, MMB-4CN-Butinaca, MDMB-4F-Butica, MDMB-4F-Butinaca and their analogs
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo , use of SCRAs can result in severe intoxication, in addition to other adverse health effects. Recent detections of AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA and MDMB-4F-BUTINACA mark a continuation in the appea…
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-Fubinaca, Cumyl-Pinaca, PB-22, and XLR-11
These results suggest that while some "off-targets" could possibly contribute to the SCRA toxidrome, particularly at high concentrations, CB1-mediated cellular dysfunction provides support for hypotheses concerning on-target, rather than off-target, toxicity. Further investigation of non-GPCR off-targets is warranted
Biology (3 works) · Cannabinoid (3 works) · Cannabis and Cannabinoid Research (3 works) · Forensic Toxicology and Drug Analysis (3 works) · Agonist (2 works) · Biochemistry (2 works) · Cannabinoid receptor (2 works) · Cannabinoid Receptor Agonists (2 works) · Chemistry (2 works) · Medicine (2 works)